The year 2013 was a pivotal one for Netflix (NASDAQ: NFLX). It was a smart move: Though creating original content was sure to be more expensive than licensing an existing show, Netflix would reap long-term savings by dealing with itself rather than continually renegotiating streaming deals with other content creators. The strategy only became more important as Netflix's streaming competition grew.
Earlier in the year, when the stock market crashed due to the coronavirus pandemic, a lot of investors were in a panic. I, however, decided to take the opportunity to capitalize on falling stock prices.
According to the Centers for Disease Control and Prevention, there are 170 vaccine candidates in development around the world. One of the more promising companies conducting trials, AstraZeneca (NYSE: AZN), had to temporarily pause its trial on Sept. 8 after a woman injected with its vaccine experienced an illness. AstraZeneca paused its vaccine trial.